# First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/first-line-nivolumab-plus-ipilimumab-versus-chemotherapy-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Solange Peters,Arnaud Scherpereel,Robin Cornelissen,Youssef Oulkhouir,Laurent Greillier,Kaplan Ma,Thomas Talbot,I. Monnet,Sandrine Hiret,P. Baas,Anna K. Nowak,Nobukazu Fujimoto,Anne S. Tsao,Aaron S. Mansfield,Sanjay Popat,X. Zhang,Nan Hu,David Balli,Thomas Spires,Gérard Zalcman |
| Citations | 266 |
| DOI | 10.1016/j.annonc.2022.01.074 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.annalsofoncology.org/article/S0923753422000837/pdf |
| OpenAlex ID | https://openalex.org/W4210792133 |
| PMID | 35124183 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Nobukazu Fujimoto](https://scholariq.org/researchers/nobukazu-fujimoto/)
- [Aaron S. Mansfield](https://scholariq.org/researchers/aaron-s-mansfield/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)

## Paper topics

- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)
- [Pleural and Pulmonary Diseases](https://scholariq.org/topics/pleural-and-pulmonary-diseases/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.